Collaborations with major national and international pharmaceutical companies have always represented the core of Abiogen Pharma’s activities, and it is thanks to these relationships that the company was established.
Networking activity has permitted the optimisation of internal research, licensing out. Partnerships have in fact the goal of strengthening the commercial impact of Abiogen Pharma’s molecules in Italy, and of spreading its presence internationally on those markets where the company is not directly involved.
The licensing out activity is destined to grow in the near future thanks to a large number of projects already in the clinical phase and consequently need to offer them the opportunities for appropriate partnerships in Italy and abroad.
Abiogen focuses its activities also in licensing In, to ensure the dynamic development of the company through the identification and implementation of business opportunities.
Abiogen’s vision and business commitment lead to the exploration of strategic opportunities that can advance its product portfolio in therapeutic areas such as the musculoskeletal, diabetology, dermatology and respiratory areas.